Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105777871B reveals high-purity cyclic pentapeptide synthesis. Solid-liquid strategy ensures supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115403660A reveals a novel solid-phase synthesis for Plecanatide, solving resin shrinkage and impurity issues to ensure high-purity pharmaceutical intermediates and cost-effective supply.
Advanced CN103467575B patent method reduces racemization and improves yield for high-purity Pasireotide manufacturing supply chain.
Discover Cpac-Bt, a novel amino protecting reagent offering mild conditions and orthogonal deprotection for complex peptide synthesis and pharmaceutical intermediate manufacturing.
Advanced liquid-phase convergent synthesis of pasireotide intermediates offers high purity and scalable production. Discover cost-effective manufacturing solutions.
Patent CN102180963B details a novel GLP-1 analogue modified with 4-hydroxycoumarin for extended half-life. Discover cost-effective microwave solid-phase synthesis strategies for diabetes therapeutics.
Patent CN102731624B enables high purity Bivalirudin production. Reduces waste and ensures supply chain continuity for global pharmaceutical manufacturers.
Novel solid-liquid phase synthesis for disulfide-bonded polypeptides. Reduces costs and improves purity for API intermediates.
Patent CN102584944A details a novel solid-phase synthesis for high-purity Eptifibatide. This method reduces impurities and offers scalable manufacturing solutions.
Discover the novel fragment-condensation method for high-purity Eptifibatide acetate. Optimize your supply chain with scalable peptide manufacturing strategies.
Novel solid-phase synthesis using protected fragments reduces impurities like [+1Gly]-eptifibatide. High purity >99.5% achievable. Cost-effective manufacturing solution.
Discover a novel N-to-C synthesis route for Carfilzomib avoiding racemization. High yield, chromatography-free purification for cost-effective API manufacturing.
Patent CN116761809A discloses Fmoc solid-phase synthesis for ACTH. Achieves 99% purity and 63% yield. Ideal for reliable API intermediate supplier partnerships.
Patent CN109748950B reveals a novel Pd-catalyzed solid-phase method for Selepressin, offering high purity and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN107176975A details solid-state Gonadorelin synthesis ensuring high purity and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Novel 3-step route for Saxagliptin intermediate manufacturing reduces cost and improves purity for pharmaceutical supply chains.
Patent CN113583088A details novel cyclic peptide synthesis targeting STRN3 for gastric cancer, offering improved stability and cell permeability for pharmaceutical manufacturing.
Patent CN107857813A details a cost-effective liquid phase synthesis for Tripeptide-29. Enhance supply chain reliability with high-purity peptide solutions.
Novel liquid-phase method for Eptifibatide reduces costs and improves scalability. Reliable supplier for high-purity pharmaceutical intermediates with commercial scale-up capability.
Patent CN118026984A enables automated rhodamine B peptide synthesis. This novel lysine derivative offers significant supply chain reliability and cost reduction advantages.